According to a new report published by Allied Market Research, titled, “Radiation Oncology Market," The radiation oncology market size was valued at $7.79 billion in 2021, and is estimated to reach $15.23 billion by 2030, growing at a CAGR of 7.8% from 2022 to 2030.
Download Free Sample Copy of The Report:
https://www.alliedmarketresearch.com/request-sample/18888
The increase in cancer due to unhealthy lifestyles and increasing consumption of carcinogenic foods across the globe are the major factors expected to boost the growth of the global radiation oncology market during the forecast period. Additionally, technological advancements in radiation oncology such as image-guided radiation therapy and imaging capabilities, digital imaging, and computer-controlled imaging equipment are expected to boost market growth during the forecast period. However, high processing costs and rise in new technology errors will restrain the market growth during the forecast period. On the contrary, the increasing number of cancer deaths and the need for effective treatment will provide an opportunity for key players to advance in the radiation oncology market in the coming years. is coming.
Among the analyzed regions, North America is expected to account for the highest market revenue in the forecast year, followed by Europe, Asia-Pacific, and LAMEA. North America has the most developed and advanced health care infrastructure, which affects the acceptance of radiation oncology procedures by cancer patients.
For Purchase Inquiry of Market Report:
https://www.alliedmarketresearch.com/purchase-enquiry/18888
Major Key Players -
BD, Isoray Inc., Provision Healthcare, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, IBA Worldwide, Nordion (Canada) Inc., Panacea Medical Technologies Pvt. Ltd
Impact of COVID-19 on the Global Radiation Oncology Industry
Many industries were affected by the Covid-19 epidemic. The pandemic favoured the healthcare industry, although not all aspects were pleasantly impacted. To treat the affected individuals, several clinics throughout the world were transformed to Covid-19 clinics.
Covid-infected patients were given prominence, and a lack of hospitals and surgeons was a severe hurdle for cancer treatment. Patients avoided going to hospitals for fear of acquiring an illness.
About Us -
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
The global Radiation Oncology Market is estimated to touch US$ 10.1 Billion by the completion of the year 2025.
The market was appreciated at US$ 5.7 Billion in the year 2016.
Technical progressions in radiotherapy caused in augmented acceptance of radiation oncology by way of main treatment track of cancer.
Progress with respect to compact innovative radiotherapy preferences; for example Tomotherapy, Gama Knife, and Cyber Knife, add to this development.
Furthermore, by way of the help of sympathetic government creativities and alertness, patients are not shy to choose for progressive treatment opportunities.
For example, as per the information of World Bank Group per head expenses on health observed substantial development of over 55.0% between the years of 1995 to 2014.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/radiation-oncology-market/request-sampleThe Radiation Oncology industry on the source of Type of Technology could span Systemic Beam Radiation Therapy, Brachytherapy [High-Dose Rate Brachytherapy, Low-Dose Rate Brachytherapy], External Beam Radiation Therapy [Volumetric Modulated Arc Therapy (VMAT), Proton Beam Therapy, Intensity Modulated Radiotherapy (IMRT), 3D Conformal Radiotherapy (3D CRT), Stereotactic Technology, Image-Guided Radiotherapy (IGRT)], and Others.The Radiation Oncology market on the source of Type of Application could span Internal Beam Radiation Therapy [Penile Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Gynecological Cancer, and Others], External Beam Radiation Therapy [Colorectal Cancer, Lung Cancer, Prostate Cancer, Head and Neck Cancer, Breast Cancer, and Others].The Radiation Oncology industry on the source of Type of Product could span Systemic Beam Radiation Therapy, Brachytherapy [Electronic Brachytherapy, See, Applicators and after loaders], External Beam Radiation Therapy [Proton Therapy {Synchrotron, Cyclotron}, Compact Advanced Radiotherapy Systems {Tomotherapy, Cyber Knife, Gamma Knife}, Electron-Emitting High-Energy Linear Accelerators {Linac}].The Radiation Oncology market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage could span North America [U.S.A, Canada], Europe [Germany, U.K.], Asia Pacific [Japan, China], Latin America [Brazil, Mexico], Middle East & Africa [South Africa].By the source of geography, North America is the most important area in Radiation Oncology industry.
